These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Well-characterized biotechnology products: evolving to meet the needs of the 21st century. Zoon KC Dev Biol Stand; 1998; 96():3-8. PubMed ID: 9890510 [No Abstract] [Full Text] [Related]
4. New hepatitis-B vaccine approved. Occup Health Saf; 1989 Oct; 58(11):24, 26. PubMed ID: 2530481 [No Abstract] [Full Text] [Related]
5. Biologicals and vaccines: regulatory perspectives. Petricciani JC Dev Biol Stand; 1986; 63():15-9. PubMed ID: 3743903 [TBL] [Abstract][Full Text] [Related]
6. Regulating recombinant DNA biologics. Crouch ML Arzneimittelforschung; 1988 Jul; 38(7):947-9. PubMed ID: 3207440 [TBL] [Abstract][Full Text] [Related]
7. Challenges and opportunities in biotechnology. Overby LR Prog Clin Biol Res; 1985; 182():425-43. PubMed ID: 2994109 [TBL] [Abstract][Full Text] [Related]
8. Definition of a well-characterized biotechnology product. Zoon K; Garnick R Dev Biol Stand; 1998; 96():191-7. PubMed ID: 9890531 [No Abstract] [Full Text] [Related]
9. FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(5):107-9. PubMed ID: 9045037 [TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B virus. Application of recombinant DNA technics to the development of hepatitis B vaccines and its diagnosis]. Hamada F Rinsho Byori; 1988 May; 36(5):548-52. PubMed ID: 2971829 [No Abstract] [Full Text] [Related]
13. New vaccine approved for 2 hepatitis viruses. AIDS Read; 2001 Jun; 11(6):298. PubMed ID: 11449920 [No Abstract] [Full Text] [Related]
14. 'Breeding' antigens for new vaccines. Cohen J Science; 2001 Jul; 293(5528):236-8. PubMed ID: 11452109 [No Abstract] [Full Text] [Related]
15. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies. Dudzinski DM Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771 [No Abstract] [Full Text] [Related]
16. FDA approval for a combined hepatitis A and B vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):806-7. PubMed ID: 11785573 [TBL] [Abstract][Full Text] [Related]
17. The challenge of integrating monoclonal antibodies into the current healthcare system. Brixner DI; Bull SA Am J Manag Care; 1997 Jun; 3(6):903-11. PubMed ID: 10170294 [TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis of hepatitis B vaccines. Zuckerman AJ Arzneimittelforschung; 1987 Jan; 37(1):87-8. PubMed ID: 2952127 [No Abstract] [Full Text] [Related]
19. Safety of hepatitis B vaccine confirmed. FDA Drug Bull; 1985 Aug; 15(2):14-5. PubMed ID: 2996962 [No Abstract] [Full Text] [Related]